Zicam Maker Urges FDA To Reverse Anosmia Finding

Law360, New York (November 23, 2009, 2:56 PM EST) -- The maker of Zicam is reportedly beseeching the U.S. Food and Drug Administration to take back its previous finding that the medication poses a threat to users because it could permanently cost them their sense of smell.

On Monday, the FDA confirmed that Matrixx Initiatives sent the agency a letter urging reversal after being turned away just last month in its quest to have the June warning lifted. The company also reportedly filed a Freedom of Information Act request, seeking a more detailed explanation of how...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.